Triad Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
LMFP
ATO
QP
Triad Investment Management's MRK Position: Q2 2026 in Review
Triad Investment Management sold out of Merck (MRK) in Q2 2026, closing a stake of 2,225 shares — an estimated $268K sold.
Triad Investment Management first reported a position in MRK in Q4 2018 and held it in 21 quarters. The position peaked at $353K in Q1 2024. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Triad Investment Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
- Triad Investment Management sold 2,225 Merck shares in Q2 2026, an estimated $268K.
- Triad Investment Management first reported a position in Merck in Q4 2018 and held it in 21 quarters.
- Triad Investment Management's Merck position peaked at $353K in Q1 2024.
- 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Triad Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.